Increased risk of hematological side-effects in psychiatric patients treated with clozapine and carbamazepine?
Junghan
U
U
Albers
M
M
Woggon
B
B
D000380:Agranulocytosis / Q000139:chemically induced; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D006402:Hematologic Diseases / Q000139:chemically induced* / Q000150:complications; D006801:Humans; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy; D012306:Risk
D002220:Carbamazepine; D003024:Clozapine